VYNE Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SHAY CAPITAL LLC | 02/17/2026 | 1.62 M | $942.29 K | 229.77% | 3.80% |
| ANSON FUNDS MANAGEMENT LP | 02/17/2026 | 1.27 M | $739.27 K | 100.00% | 2.98% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.00 M | $580.10 K | 100.00% | 2.34% |
| 02/11/2026 | 945.00 K | $548.20 K | 100.00% | 2.21% | |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 638.49 K | $370.00 K | 43.03% | 1.49% |
| 02/18/2026 | 500.55 K | $290.37 K | 100.00% | 1.17% | |
| VANGUARD GROUP INC | 01/29/2026 | 314.55 K | $182.44 K | 65.22% | 0.74% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 264.91 K | $153.68 K | -8.65% | 0.62% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 253.79 K | $147.22 K | 100.00% | 0.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 225.15 K | $130.61 K | 64.20% | 0.53% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 220.00 K | $127.62 K | -0.36% | 0.51% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 163.10 K | $94.61 K | 188.16% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 100.34 K | $58.21 K | 73.71% | 0.23% |
| RANGELEY CAPITAL, LLC | 02/17/2026 | 100.00 K | $58.01 K | 100.00% | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 81.37 K | $47.20 K | -23.57% | 0.19% |
| XTX TOPCO LTD | 02/17/2026 | 79.04 K | $45.85 K | 100.00% | 0.18% |
| JANE STREET GROUP, LLC | 02/12/2026 | 72.36 K | $41.97 K | -50.82% | 0.17% |
| UBS GROUP AG | 01/29/2026 | 62.76 K | $36.40 K | 1,026.36% | 0.15% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 53.96 K | $31.00 K | 50.22% | 0.13% |
| BLACKROCK, INC. | 02/12/2026 | 44.41 K | $25.76 K | 0.00% | 0.10% |
| CITADEL ADVISORS LLC | 02/17/2026 | 30.53 K | $17.71 K | 100.00% | 0.07% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 25.33 K | $15.00 K | 100.00% | 0.06% |
| FNY INVESTMENT ADVISERS, LLC | 01/16/2026 | 25.00 K | $14.00 K | 100.00% | 0.06% |
| NORTHERN TRUST CORP | 02/17/2026 | 23.11 K | $13.41 K | 0.00% | 0.05% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/12/2026 | 18.30 K | $10.61 K | 0.00% | 0.04% |
| STATE STREET CORP | 02/13/2026 | 15.77 K | $9.15 K | 0.00% | 0.04% |
| HARVEST INVESTMENT SERVICES, LLC | 02/17/2026 | 11.06 K | $6.42 K | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 3.57 K | $2.07 K | -0.83% | 0.01% |
| ROYAL BANK OF CANADA | 02/17/2026 | 2.44 K | $1.00 K | 0.04% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.68 K | $973 | 9.46% | 0.00% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 1.43 K | $827 | -99.76% | 0.00% |
| MB, LEVIS & ASSOCIATES, LLC | 01/14/2026 | 1.04 K | $604 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/10/2026 | 800 | $464 | 100.00% | 0.00% |
| HURLEY CAPITAL, LLC | 02/17/2026 | 561 | $325 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 146 | $85 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 65 | $38 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 43 | $25 | -95.28% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 02/13/2026 | 25 | $15 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 01/21/2026 | 10 | $6 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VYNE Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 50 institutional investors and hedge funds held shares of VYNE Therapeutics Inc. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 1.63 M
UBS Group AG: 179,784
FNY Investment Advisers, LLC: 35,000
COMMONWEALTH EQUITY SERVICES, LLC: 18,298
MB, LEVIS & ASSOCIATES, LLC: 1,041
Newbridge Financial Services Group, Inc.: 10
19.14% of VYNE Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 9.66 M shares in the last 24 months. This purchase volume represents approximately $5.70 M in transactions.